ORIC PHARMACEUTICALS INC. - COMMON STOCK

ORIC Pharmaceuticals Reports Initial Clinical Data Being Presented at ASCO from Phase 1b Trial of ORIC-101 in Combination with Nab-Paclitaxel

02 Jun 2021 16:55:00 By Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference

26 May 2021 16:30:00 By Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Host Conference Call with KOL to Review Initial Data Being Presented at ASCO from Phase 1b Study of ORIC-101 in Combination with Nab-paclitaxel

25 May 2021 08:00:03 By Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports First Quarter 2021 Financial Results and Operational Update

06 May 2021 16:05:01 By Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Present Initial Data from Ongoing Phase 1b Study of ORIC-101 in Combination with Nab-paclitaxel at the 2021 ASCO Annual Meeting

28 Apr 2021 16:05:01 By Nasdaq GlobeNewswire

ORIC Pharmaceuticals Presents Posters on Four Programs at the 2021 American Association for Cancer Research (AACR) Annual Meeting

12 Apr 2021 06:30:00 By Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Update

23 Mar 2021 16:05:00 By Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Present Posters on Four Programs at the 2021 American Association for Cancer Research (AACR) Annual Meeting

10 Mar 2021 16:30:00 By Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

02 Mar 2021 06:30:00 By Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

03 Feb 2021 16:30:00 By Nasdaq GlobeNewswire

ORIC Pharmaceuticals Provides Corporate Update and Highlights Key 2021 Milestones

11 Jan 2021 06:30:00 By Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference

04 Jan 2021 06:30:00 By Nasdaq GlobeNewswire